James A. Geraghty

Who is James A. Geraghty?

James Geraghty joined Genzyme in 1992. He is responsible for managing

the cardiovascular business unit, including current programs as well as

product acquisition and partnering transactions. He led Genzyme’s

acquisition of SangStat Medical Corporation in 2003 and has also served

as president of Genzyme Europe. Prior to joining Genzyme, Mr. Geraghty

was vice president of marketing and strategic planning for

Baxter/Caremark International. He has also worked as a consultant on

international health care strategy at Bain and Company. Mr. Geraghty

has a J.D. from Yale Law School, an M.S. from the University of

Pennsylvania and a B.A. from Georgetown University.